abstract |
Anti-TRGV9 antibodies or antigen-binding fragments thereof are described. Also described are nucleic acids encoding the antibody, compositions comprising the antibody, methods of producing the antibody, and methods of using the antibody to treat or prevent a disease such as cancer. |